Teresa Calimeri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Cerebrospinal Fluid

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

Bioengineering (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Teresa Calimeri, Andrés José Maria Ferreri
CNS prophylaxis in large B-cell lymphomas: A balance with three pans. British journal of haematology (2024)
Michela Destito, Aldo Marzullo, Riccardo Leone, Paolo Zaffino, Sara Steffanoni, Federico Erbella, Francesco Calimeri, Nicoletta Anzalone, Elena De Momi, Andrés José Maria Ferreri, Teresa Calimeri, Maria Francesca Spadea
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients. Bioengineering (Basel, Switzerland) 10 (3) (2023)
Elena Flospergher, Fabrizio Marino, Teresa Calimeri, Maria Giulia Cangi, Andrés José María Ferreri, Maurilio Ponzoni, Lucia Bongiovanni
Primary central nervous system marginal zone lymphoma. British journal of haematology (2023)
Sara Steffanoni, Teresa Calimeri, Sarah Marktel, Rosamaria Nitti, Marco Foppoli, Andrés José Maria Ferreri
Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review. Cancers 15 (2) (2023)
Michela Destito, Aldo Marzullo, Riccardo Leone, Paolo Zaffino, Sara Steffanoni, Federico Erbella, Francesco Calimeri, Nicoletta Anzalone, Elena De Momi, Andrés José Maria Ferreri, Teresa Calimeri, Maria Francesca Spadea
Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients. Bioengineering (Basel, Switzerland) 10 (3) (2023)
Sara Steffanoni, Teresa Calimeri, Sarah Marktel, Rosamaria Nitti, Marco Foppoli, Andrés José Maria Ferreri
Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review. Cancers 15 (2) (2023)
Angelo Corti, Teresa Calimeri, Flavio Curnis, Andrés José Maria Ferreri
Targeting the Blood-Brain Tumor Barrier with Tumor Necrosis Factor-α. Pharmaceutics 14 (7) (2022)
Andrés José Maria Ferreri, Teresa Calimeri, Paolo Lopedote, Ilaria Francaviglia, Rita Daverio, Chiara Iacona, Cristina Belloni, Sara Steffanoni, Alessandro Gulino, Elena Anghileri, Angelo Diffidenti, Annamaria Finardi, Filippo Gagliardi, Nicoletta Anzalone, Alessandro Nonis, Roberto Furlan, Daniela De Lorenzo, Maria R Terreni, Vittorio Martinelli, Marianna Sassone, Marco Foppoli, Piera Angelillo, Elena Guggiari, Andrea Falini, Pietro Mortini, Massimo Filippi, Vittoria Tarantino, Marica Eoli, Fabio Ciceri, Claudio Doglioni, Claudio Tripodo, Massimo Locatelli, Maria Giulia Cangi, Maurilio Ponzoni
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study. British journal of haematology 193 (3) (2021)
Teresa Calimeri, Andrés José Maria Ferreri
Prevention of CNS relapse in diffuse large B-cell lymphoma: common sense prevails where science fails. British journal of haematology 190 (5) (2020)
Andrés José Maria Ferreri, Teresa Calimeri, Gian Marco Conte, Dario Cattaneo, Federico Fallanca, Maurilio Ponzoni, Eloise Scarano, Flavio Curnis, Alessandro Nonis, Paolo Lopedote, Giovanni Citterio, Letterio Salvatore Politi, Marco Foppoli, Stefania Girlanda, Marianna Sassone, Salvatore Perrone, Caterina Cecchetti, Fabio Ciceri, Claudio Bordignon, Angelo Corti, Nicoletta Anzalone
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. Blood 134 (3) (2019)